| Literature DB >> 27740510 |
Rémi Béranger1, Ronan Garlantézec, Gaïd Le Maner-Idrissi, Agnès Lacroix, Florence Rouget, Jessica Trowbridge, Charline Warembourg, Christine Monfort, Florent Le Gléau, Marylène Jourdin, Luc Multigner, Sylvaine Cordier, Cécile Chevrier.
Abstract
BACKGROUND: Glycol ethers (GE) are widely used organic solvents. Despite the potential neurotoxicity of several families of organic solvents, little is known about the impact of GE on the neurodevelopment of infants and children.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27740510 PMCID: PMC5381990 DOI: 10.1289/EHP39
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Main parent compounds for each alkyloacetic metabolite and their sources in France (2000–2006).
| Metabolites | Parent glycol ethers | Cosmetics | Cleaning agents | Paint, varnishes, and inks | Biocides | Drugs |
|---|---|---|---|---|---|---|
| MAA | DEGME, TEGME, TEDGME | Not reported | Yes | Not reported | Not reported | Not reported |
| EAA | DEGEE, TEGEE | Yes | Yes | Yes | Yes | Yes |
| EEAA | DEGEE, TEGEE | Yes | Yes | Yes | Yes | Yes |
| BAA | EGBE, DEGBE | Yes | Yes | Yes | Yes | Not reported |
| PhAA | EGPhE | Yes | Not reported | Not reported | Yes | Yes |
| Abbreviations: BAA, 2-butoxyacetic acid; DEGBE, 2-(2-butoxyethoxy)ethanol; DEGEE, 2-(2-ethoxyethoxy)ethanol; DEGME, 2-(2-methoxyethoxy)ethanol; EAA, ethoxyacetic acid; EEAA, ethoxyethoxyacetic acid; EGBE, 2-butoxyethanol; EGPhE, 2-phenoxyethanol; MAA, methoxyacetic acid; PhAA, phenoxyacetic acid; TEGDME, 1,2-bis(methoxyethoxy)ethane; TEGEE, 2-[2-(2-ethoxyethoxy)ethoxy]ethanol; TEGME, 2-[2-(2-methoxyethoxy)ethoxy]ethanol. Data from AFSSET (2008). | ||||||
Concentrations of GE metabolites in urine samples of 204 pregnant women randomly selected from the PELAGIE mother–child cohort.
| Urinary metabolites | Standard for calibration | Frequency of detection (%) | Median (mg/L) | Interquartile range |
|---|---|---|---|---|
| Methoxyacetic acid (MAA) | Acros Organic | 197 (97%) | 0.062 | (0.033–0.100) |
| Ethoxyacetic acid (EAA) | Sigma Aldrich | 191 (94%) | 0.016 | (0.010–0.027) |
| Ethoxyethoxyacetic acid (EEAA) | A2S | 185 (91%) | 0.028 | (0.010–0.079) |
| 2-Butoxyacetic acid (BAA) | Acros Organic | 203 (100%) | 0.042 | (0.022–0.070) |
| Phenoxyacetic acid (PhAA) | Dr Erhenstorfer | 204 (100%) | 0.390 | (0.170–0.990) |
| The limit of detection was 0.003 mg/L for all metabolites. | ||||
Characteristics of the population (n = 204).
| Characteristic | Mean ± SD | |
|---|---|---|
| Maternal factors | ||
| Maternal age at conception (years) | 204 (100.0) | 30.3 ± 4.2 |
| Parity | ||
| 0 | 82 (40.2) | |
| ≥ 1 | 122 (59.8) | |
| Education | ||
| ≤ 12 years | 67 (32.8) | |
| > 12 years | 136 (66.7) | |
| Missing | 1 (0.5) | |
| Body mass index (kg/m2) | ||
| ≤ 25 | 164 (80.4) | |
| > 25 | 39 (19.1) | |
| Missing | 1 (0.5) | |
| Fish consumption before pregnancy | ||
| Eaten no more than once a week | 144 (70.6) | |
| Eaten more than once a week | 60 (29.4) | |
| Alcohol consumption during pregnancy | ||
| No | 175 (85.8) | |
| Yes | 25 (12.2) | |
| Missing | 4 (2.0) | |
| Tobacco consumption in the households at age 6 years | ||
| None | 115 (56.4) | |
| ≤ 10 cigarettes per day | 45 (22.1) | |
| > 10 cigarettes per day | 44 (21.5) | |
| Household renovation during childhood likely to expose to organic solvents | ||
| No | 68 (33.8) | |
| Yes | 133 (66.2) | |
| WAIS score | 202 (99.0) | 93.6 ± 11.22 |
| Urinary creatinine (g/L) | 1.06 ± 0.46 | |
| Child factors | ||
| Sex | ||
| Boys | 95 (46.6) | |
| Girls | 109 (53.4) | |
| Birth weight (g) | 3,432 ± 392 | |
| Gestational age at birth (weeks) | 39.5 ± 1.2 | |
| Breastfeeding | ||
| None | 57 (27.9) | |
| ≤ 16 weeks | 69 (33.8) | |
| > 16 weeks | 77 (37.8) | |
| Missing | 1 (0.5) | |
| HOME score | 46.3 ± 3.8 | |
| Investigator | ||
| 1 | 97 (47.6) | |
| 2 | 107 (52.4) |
Description of neurocognitive abilities and visuospatial skills of the 6-year-old children (n = 204).
| Outcome | Median (25th–75th percentile) | 90th percentile | |
|---|---|---|---|
| Neurocognitive abilities | |||
| WISC–Verbal Comprehension Index | 204 | 108.0 (98.0–116.0) | 126.0 |
| WISC–Working Memory Index | 200 | 104.5 (97.0–118.0) | 125.5 |
| Visuospatial skills | |||
| NEPSY–Design Copying | 204 | 13 (10–15) | 16 |
| NEPSY–Arrows | 204 | 12 (11–14) | 15 |
Associations between concentrations of glycol ether metabolite in mothers’ prenatal urine samples and the WISC-IV scores of their 6-year-old children.
| Metabolite (mg/L) | WISC-Verbal Comprehension Index | WISC-Working Memory Index | ||||
|---|---|---|---|---|---|---|
| βcrude (95% CI) | βadjusted (95% CI) | βcrude (95% CI) | βadjusted (95% CI) | |||
| MAA | ||||||
| ≤ 0.043 | 68 | Reference | Reference | 67 | Reference | Reference |
| > 0.043–0.081 | 67 | 0.59 (–4.74, 5.93) | 1.75 (–3.15, 6.65) | 65 | –0.04 (–5.03, 4.94) | 0.40 (–4.35, 5.15) |
| > 0.081 | 69 | 4.06 (–1.24, 9.36) | 2.87 (–2.00, 7.74) | 68 | 0.55 (–4.38, 5.48) | –0.33 (–5.03, 4.37) |
| Continuous (log) | 204 | 1.39 (–0.51, 3.30) | 0.95 (–0.83, 2.73) | 200 | 1.16 (–0.64, 2.96) | 1.00 (–0.74, 2.74) |
| EAA | ||||||
| ≤ 0.011 | 68 | Reference | Reference | 67 | Reference | Reference |
| > 0.011–0.021 | 67 | 2.73 (–2.63, 8.09) | 3.35 (–1.66, 8.36) | 65 | 0.34 (–4.65, 5.32) | 0.09 (–4.70, 4.88) |
| > 0.021 | 69 | 1.42 (–3.90, 6.74) | –1.40 (–6.58, 3.78) | 68 | –0.69 (–5.62, 4.24) | –3.16 (–8.13, 1.80) |
| Continuous (log) | 204 | 0.29 (–1.96, 2.55) | –0.29 (–2.48, 1.89) | 200 | 0.33 (–1.78, 2.44) | –0.25 (–2.35, 1.86) |
| EEAA | ||||||
| ≤ 0.016 | 68 | Reference | Reference | 67 | Reference | Reference |
| > 0.016–0.050 | 66 | 4.97 (–0.36, 10.31) | 4.51 (–0.39, 9.40) | 65 | 1.32 (–3.66, 6.30) | 0.41 (–4.31, 5.13) |
| > 0.050 | 70 | 0.44 (–4.82, 5.70) | –0.22 (–5.30, 4.86) | 68 | 1.31 (–3.62, 6.24) | 0.16 (–4.78, 5.09) |
| Continuous (log) | 204 | 0.53 (–0.62, 1.69) | 0.31 (–0.79, 1.42) | 200 | 0.47 (–0.63, 1.57) | 0.21 (–0.87, 1.29) |
| BAA | ||||||
| ≤ 0.028 | 67 | Reference | Reference | 66 | Reference | Reference |
| > 0.028–0.058 | 68 | –1.14 (–6.50, 4.23) | –0.58 (–5.55, 4.40) | 67 | –1.09 (–6.06, 3.87) | –1.57 (–6.39, 3.26) |
| > 0.058 | 69 | –1.91 (–7.26, 3.43) | –2.25 (–7.22, 2.72) | 67 | –0.27 (–5.24, 4.69) | –1.49 (–6.32, 3.34) |
| Continuous (log) | 204 | –0.22 (–2.59, 2.15) | –0.61 (–2.84, 1.61) | 200 | 1.04 (–1.15, 3.22) | 0.45 (–1.71, 2.60) |
| PhAA | ||||||
| ≤ 0.224 | 68 | Reference | Reference | 68 | Reference | Reference |
| > 0.224–0.781 | 67 | –5.16 (–10.44, 0.12) | –4.72 (–9.61, 0.16) | 65 | –0.17 (–5.14, 4.80) | 0.41 (–4.34, 5.16) |
| > 0.781 | 69 | –6.61 (–11.89, –1.37) | –6.53 (–11.44, –1.62) | 67 | 0.35 (–4.48, 5.28) | 0.93 (–3.85, 5.70) |
| Continuous (log) | 204 | NA | NA | 200 | 0.24 (–0.85, 1.32) | 0.08 (–0.97, 1.14) |
| Abbreviations: BAA, 2-butoxyacetic acid; EAA, ethoxyacetic acid; EEAA, ethoxyethoxyacetic acid; MAA, methoxyacetic acid; NA: Not applicable, significant departure from linearity based on restricted cubic spline model; PhAA, phenoxyacetic acid. All adjusted models were adjusted for education, WAIS score, HOME score, creatinine concentration, and investigator who administered the neurocognitive test. Additional adjustments were made for breastfeeding (MAA), alcohol consumption (EEAA), parity (BAA), and fish consumption (BAA). WISC-IV scores are based on a scale with a mean of 100 and a standard deviation of 15 (minimum–maximum, 40–160). | ||||||
Associations between concentrations of glycol ether metabolite in mothers’ prenatal urine samples and the visuospatial skills (NEPSY) of their 6-year-old children.
| Metabolite (mg/L) | NEPSY–Design Copying | NEPSY–Arrows | ||||
|---|---|---|---|---|---|---|
| βcrude (95% CI) | βadjusted (95% CI) | βcrude (95% CI) | βadjusted (95% CI) | |||
| MAA | ||||||
| ≤ 0.043 | 68 | Reference | Reference | 68 | Reference | Reference |
| > 0.043–0.081 | 67 | 0.02 (–0.08, 0.11) | 0.02 (–0.08, 0.12) | 67 | 0.02 (–0.08, 0.11) | 0.02 (–0.08, 0.12) |
| > 0.081 | 69 | 0.05 (–0.05, 0.14) | 0.04 (–0.06, 0.13) | 69 | 0.03 (–0.07, 0.12) | 0.01 (–0.08, 0.11) |
| Continuous (log) | 204 | 0.02 (–0.01, 0.06) | 0.02 (–0.02, 0.06) | 204 | 0.01 (–0.03, 0.04) | 0.01 (–0.03, 0.04) |
| EAA | ||||||
| ≤ 0.011 | 68 | Reference | Reference | 68 | Reference | Reference |
| > 0.011–0.021 | 67 | 0.04 (–0.05, 0.14) | 0.03 (–0.07, 0.13) | 67 | 0.01 (–0.09, 0.10) | 0.01 (–0.10, 0.11) |
| > 0.021 | 69 | –0.05 (–0.14, 0.05) | –0.11 (–0.21, 0.00) | 69 | 0.01 (–0.09, 0.10) | –0.02 (–0.12, 0.09) |
| Continuous (log) | 204 | 0.00 (–0.04, 0.04) | –0.01 (–0.06, 0.03) | 204 | 0.01 (–0.03, 0.05) | 0.00 (–0.04, 0.05) |
| EEAA | ||||||
| ≤ 0.016 | 68 | Reference | Reference | 68 | Reference | Reference |
| > 0.016–0.050 | 66 | –0.04 (–0.14, 0.05) | –0.06 (–0.16, 0.04) | 66 | –0.07 (–0.17, 0.03) | –0.08 (–0.18, 0.02) |
| > 0.050 | 70 | –0.07 (–0.16, 0.03) | –0.10 (–0.20, 0.01) | 70 | 0.01 (–0.09, 0.10) | 0.00 (–0.11, 0.10) |
| Continuous (log) | 204 | 0.00 (–0.03, 0.02) | –0.01 (–0.03, 0.01) | 204 | 0.01 (–0.01, 0.03) | 0.01 (–0.01, 0.03) |
| BAA | ||||||
| ≤ 0.028 | 67 | Reference | Reference | 67 | Reference | Reference |
| > 0.028–0.058 | 68 | –0.01 (–0.10, 0.09) | –0.01 (–0.11, 0.09) | 68 | 0.00 (–0.09, 0.10) | 0.00 (–0.10, 0.10) |
| > 0.058 | 69 | –0.02 (–0.11, 0.08) | –0.03 (–0.13, 0.06) | 69 | –0.03 (–0.13, 0.06) | –0.05 (–0.15, 0.05) |
| Continuous (log) | 204 | 0.02 (–0.02, 0.06) | 0.01 (–0.04, 0.05) | 204 | 0.00 (–0.04, 0.05) | –0.01 (–0.05, 0.04) |
| PhAA | ||||||
| ≤ 0.224 | 68 | Reference | Reference | 68 | Reference | Reference |
| > 0.224–0.781 | 67 | 0.00 (–0.10, 0.10) | 0.00 (–0.09, 0.10) | 67 | 0.05 (–0.05, 0.14) | 0.05 (–0.05, 0.15) |
| > 0.781 | 69 | –0.01 (–0.11, 0.08) | –0.01 (–0.11, 0.08) | 69 | 0.03 (–0.07, 0.13) | 0.04 (–0.06, 0.14) |
| Continuous (log) | 204 | 0.00 (–0.02, 0.02) | –0.01 (–0.03, 0.02) | 204 | 0.01 (–0.01, 0.03) | 0.01 (–0.02, 0.03) |
| Abbreviations: BAA, 2-butoxyacetic acid; EAA, ethoxyacetic acid; EEAA, ethoxyethoxyacetic acid; MAA, methoxyacetic acid; PhAA, phenoxyacetic acid. All adjusted models were adjusted for education, WAIS score, HOME score, creatinine concentration, and investigator who administered the neurocognitive test. Additional adjustments were made for breastfeeding (MAA), number of cigarettes smoked per day in the household at age 6 (MAA, EEAA), prepregnancy maternal body mass index (EAA, EEAA, BAA), maternal age (EAA), household renovation likely to involve exposure to organic solvents (EAA), alcohol consumption (EEAA), parity (BAA,) and fish consumption (BAA). For each NEPSY subtest, the mean scaled score was 10 and the standard deviation was 3 (minimum–maximum, 1–19). | ||||||